Arcutis Biotherapeutics, Inc. Announced Findings From the Skin Insights: Uncovering Psoriasis Survey

IPC Corporate Member Arcutis Biotherapeutics, Inc. announced findings from the Skin Insights: Uncovering Psoriasis Survey, a national survey of 507 adults 18 and older diagnosed with plaque psoriasis that are on topical treatments. The online survey was designed to reveal insights into the emotional impact of the disease and challenges related to currently available topical treatments.

IFPA and IPC Partnership One Year Later — Joining the Clinical and Patient Perspectives

Meet Our Newest Councilors

IPC and IFPA Joint Statement on Diversity and Inclusion

Also Read

Press Release

Amgen Announced the United States Food and Drug Administration (FDA) Approval of AMJEVITA™

Amgen receives approval from the United States Food and Drug Administration (FDA) for AMJEVITA™, a biosimilar for adults with psoriasis and psoriatic arthritis.

Tuesday, February 7, 2023

Press Release

Bristol Myers Squibb Announces the Committee for Medicinal Products for Human Use (CHMP) has Recommended the Approval of Sotyktu (Deucravacitinib) for the Treatment of Adults with Moderate to Severe Plaque Psoriasis

This announcement follows the September 2022 approval from the U.S. Food and Drug Administration (FDA) and the Japan’s Ministry of Health, Labour, and Welfare.

Tuesday, January 31, 2023

Personalized Treatment

Focus on Psoriasis: A Report from the 2022 IPC Think Tank – Miami

Under the title, What’s Next in Psoriasis? From Maintenance to Disease Modification, the 2022 IPC Think Tank scientific symposium was held on Friday, December 9th, in Miami, Florida. Read the full report or a summary of the five psoriasis focused sessions.

Tuesday, January 24, 2023

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Advancing Knowledge. Enhancing Care.

Advancing Knowledge. Enhancing Care.

Arcutis Biotherapeutics, Inc. Announced Findings From the Skin Insights: Uncovering Psoriasis Survey

Leave a Reply Cancel reply

Categories

Recent Posts